» Articles » PMID: 37801372

Agreement Between Self-reports and Urine Toxicology Measures of Illicit Methamphetamine and Cocaine Use During Early Pregnancy

Overview
Journal J Addict Med
Specialty Psychiatry
Date 2023 Oct 6
PMID 37801372
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to assess agreement between self-report and urine toxicology measures assessing use of 2 illicit simulants (methamphetamine and cocaine) during early pregnancy.

Methods: This cross-sectional study of 203,053 pregnancies from 169,709 individuals receiving prenatal care at Kaiser Permanente Northern California between January 1, 2011, and December 31, 2019, assessed agreement ( κ , sensitivity, and specificity) between self-reported frequency and urine toxicology measures of methamphetamine and cocaine early in pregnancy.

Results: Prenatal use of the illicit stimulants was rare according to toxicology (n = 244 [0.12%]) and self-report measures (n = 294 [0.14%]). Agreement between these measures was low ( κ < 0.20). Of the 498 positive pregnancies, 40 (8.03%) screened positive on both measures, 204 (40.96%) screened positive on toxicology tests only, and 254 (51.00%) screened positive by self-report only. Relative to toxicology tests, sensitivity of any self-reported use was poor with 16.39% (95% confidence interval [CI], 11.75%-21.04%) of pregnancies with a positive toxicology test self-reporting any use in pregnancy. Relative to self-report, sensitivity of toxicology tests was also poor with 13.61% (95% CI, 9.69%-17.52%) of pregnancies who self-reported any use having positive urine toxicology tests. The sensitivity improved slightly at higher frequencies of self-reported use: daily, 17.50% (95% CI, 5.72%-29.29%); weekly, 25.00% (95% CI, 11.58%-38.42%); and monthly or less, 11.06% (95% CI, 6.89%-15.23%). Specificity was high (>99%), reflecting the high negative rate of use.

Conclusions: Findings suggest that using self-report and toxicology measures in combination likely provides the most accurate information on methamphetamine and cocaine use in early pregnancy. Findings also highlight the need to provide supportive nonstigmatizing environments in which pregnant individuals feel comfortable disclosing substance use without fear of punishment.

Citing Articles

Implementing Best Practice When Screening Birthing People for a Substance Use Disorder.

Kaufman S, Suplee P, Campbell-Oparaji D, Blumenfeld J J Midwifery Womens Health. 2024; 69(6):952-957.

PMID: 39444170 PMC: 11622360. DOI: 10.1111/jmwh.13697.

References
1.
Large M, Smith G, Sara G, Paton M, Kedzior K, Nielssen O . Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings. Int J Methods Psychiatr Res. 2012; 21(2):134-48. PMC: 6878377. DOI: 10.1002/mpr.1350. View

2.
Goler N, Armstrong M, Taillac C, Osejo V . Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinatol. 2008; 28(9):597-603. DOI: 10.1038/jp.2008.70. View

3.
Moeller K, Lee K, Kissack J . Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008; 83(1):66-76. DOI: 10.4065/83.1.66. View

4.
Garg M, Garrison L, Leeman L, Hamidovic A, Borrego M, Rayburn W . Validity of Self-Reported Drug Use Information Among Pregnant Women. Matern Child Health J. 2015; 20(1):41-47. PMC: 4713294. DOI: 10.1007/s10995-015-1799-6. View

5.
Moeller K, Kissack J, Atayee R, Lee K . Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens. Mayo Clin Proc. 2017; 92(5):774-796. DOI: 10.1016/j.mayocp.2016.12.007. View